Prophylactic cranial irradiation in lung cancer

Current Opinion in Oncology

Volumn 22, Issue 2, 2010, Pages 94-101

  Blanchard, Pierre ^a   Le Péchoux, Cécile ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Combined modality treatment; Nonsmall cell lung cancer; Prophylactic cranial irradiation; Small cell lung cancer

Indexed keywords

ALOPECIA; AMNESIA; ATAXIA; BRAIN METASTASIS; CANCER PREVENTION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DEMENTIA; FATIGUE; FRACTIONATION; HEADACHE; HUMAN; INTELLECTUAL IMPAIRMENT; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NAUSEA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SEIZURE; SKULL IRRADIATION; VOMITING;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 76749156703     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32833500ef     Document Type: Review

References (38)

1. Hochstenbag MM, Twijnstra A, Wilmink JT, et al. Asymptomatic brain me-tastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 2000; 48:243-248.
2. Hirsch FR, Paulson OB, Hansen HH, Vraa-Jensen J. Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings. Cancer 1982; 50:2433-2437.
3. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB nonsmall-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13:1880-1892.
4. Andre F, Grunenwald D, Pujol JL, et al. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer 2001; 91:2394-2400.
5. Gaspar LE, Chansky K, Albain KS, et al. Time from treatment to subsequent diagnosis of brain metastases in stage III nonsmall-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol 2005; 23:2955-2961.
6. Strauss GM, Herndon JE, Sherman DD, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA nonsmall-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992; 10:1237-1244.
7. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006; 7:719-727.
8. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected nonsmall-cell lung cancer. N Engl J Med 2004; 350:351-360.
9. Pottgen C, Eberhardt W, Grannass A, et al. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. J Clin Oncol 2007; 25:4987-4992.
10. Bajard A, Westeel V, Dubiez A, et al. Multivariate analysis of factors predictive of brain metastases in localised nonsmall cell lung carcinoma. Lung Cancer 2004; 45:317-323.
11. Carmichael J, Crane JM, Bunn PA, et al. Results of therapeutic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 1988; 14:455-459.
12. Cox JD, Stanley K, Petrovich Z, et al. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981; 245:469-472.
13. Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995; 87:183-190.
14. Shaw EG, Su JQ, Eagan RT, et al. Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. J Clin Oncol 1994; 12:2327-2332.
15. Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005; 23:6207-6219.
16. Aroney RS, Aisner J, Wesley MN, et al. Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. Cancer Treat Rep 1983; 67:675-682.
17. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1997; 33:1752-1758.
18. Laplanche A, Monnet I, Santos-Miranda JA, et al. Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Lung Cancer 1998; 21:193-201.
19. Ohonoshi T, Ueoka H, Kawahara S, et al. Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response: a long-term follow-up result. Lung Cancer 1993; 10:47-54.
20. Wagner H, Kim K, Turrisi A, et al. A randomized phase III study of prophylactic cranial irradiation vs observation in patients with small cell lung cancer achieving a complete response: final report of an incomplete trial by the ECOG and RTOG. Proc Am Soc Clin Oncol 1996; 15:376.
21. Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999; 341:476-484.
22. Meert AP, Paesmans M, Berghmans T, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001; 1:5.
23. Patel S, Macdonald OK, Suntharalingam M. Evaluation of the use of prophy-lactic cranial irradiation in small cell lung cancer. Cancer 2009; 115:842-850.
24. Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009; 10:467-474.
25. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007; 357:664-672.
26. Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms-results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol 2009; 27:78-84.
27. Lester JF, Coles B, Macbeth FR. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for nonsmall cell lung cancer. Cochrane Database Syst Rev 2005:CD005221.
28. Mira JG, Miller TP, Crowley JJ. Chest irradiation vs. chest irradiation plus chemotherapy with or without prophylactic brain radiotherapy in localized nonsmall lung cancer: a Southwest Oncology Group Study. Int J Radiat Oncol Biol Phys 1990; 19:145.
29. Russell AH, Pajak TE, Selim HM, et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1991; 21:637-643.
30. Umsawasdi T, Valdivieso M, Chen TT, et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease nonsmall cell lung cancer. J Neurooncol 1984; 2:253-259.
31. Gore EM, Bae K, Wong S, et al. A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced nonsmall cell lung cancer: initial analysis of Radiation Therapy Oncology Group 0214 [abstract #7506]. J Clin Oncol 2009; 27 (Suppl).
32. Cull A, Gregor A, Hopwood P, et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 1994; 30A:1067-1074.
33. Komaki R, Meyers CA, Shin DM, et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995; 33:179-182.
34. Grosshans DR, Meyers CA, Allen PK, et al. Neurocognitivefunction in patients with small cell lung cancer. effect of prophylactic cranial irradiation. Cancer 2008; 112:589-595.
35. Van Oosterhout AG, Ganzevles PG, WilminkJT, et al. Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 34:1037-1044.
36. Ahles TA, Silberfarb PM, Herndon J 2nd, et al. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B. J Clin Oncol 1998; 16:1954-1960.
37. Le Pechoux C, Laplanche A, Faivre Finn C, et al. Neuro-cognitive follow-up among patients with limited small cell cancer (SCLC) treated with two different doses of prophylactic cranial irradiation (PCI) according to the intergroup phase III trial (PCI99-01, IFCT 99-01, EORTC 22003-08004, RTOG 0212). J Thorac Oncol 2009; 4:S393.
38. Lee JJ, Bekele BN, Zhou X, et al. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 2006; 24:3597-3603.